Outcome and Human Epithelial Growth Factor Receptor (HER) 1-4 status in invasive breast carcinomas with proliferation indices evaluated using bromodeoxyuridine (BrdU) labelling-Reference-Cited by-同舟云学术

Outcome and Human Epithelial Growth Factor Receptor (HER) 1-4 status in invasive breast carcinomas with proliferation indices evaluated using bromodeoxyuridine (BrdU) labelling

Published:2004-03-04 Issue:3 Volume:6 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

Tovey Sian M,Witton Caroline J,Bartlett John MS,Stanton Peter D,Reeves Jonathan R,Cooke Timothy G

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/bcr783.pdf

Reference42 articles.

1. Amadori D, Silvestrini R: Prognostic and predictive value of thymidine labelling index in breast cancer. Breast Cancer Res Treat. 1998, 51: 267-281. 10.1023/A:1006140629766.

2. Rew DA, Wilson GD: Cell production rates in human tissues and tumours and their significance. Part 1: an introduction to the techniques of measurement and their limitations. Eur J Surg Oncol. 2000, 26: 227-238. 10.1053/ejso.1999.0781.

3. Goodson WH, Moore DH, Ljung BM, Chew K, Mayall B, Smith HS, Waldman FM: The prognostic value of proliferation indices: a study with in vivo bromodeoxyuridine and Ki-67. Breast Cancer Res Treat. 2000, 59: 113-123. 10.1023/A:1006344010050.

4. Yarden Y, Sliwkowski MX: Untangling the ErbB signalling network. Nat Rev Mol Cell Biol. 2001, 2: 127-137. 10.1038/35052073.

5. Lemoine NR, Barnes DM, Hollywood DP, Hughes CM, Smith P, Dublin E, Prigent SA, Gullick WJ, Hurst HC: Expression of the ERBB3 gene product in breast cancer. Br J Cancer. 1992, 66: 1116-1121.

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HER3 receptor and its role in the therapeutic management of metastatic breast cancer;Journal of Translational Medicine;2024-07-17

2. HER4 Affects Sensitivity to Tamoxifen and Abemaciclib in Luminal Breast Cancer Cells and Restricts Tumor Growth in MCF-7-Based Humanized Tumor Mice;International Journal of Molecular Sciences;2024-07-08

3. The impact of nitric oxide on HER family post-translational modification and downstream signaling in cancer;Frontiers in Physiology;2024-03-27

4. HER3: Toward the Prognostic Significance, Therapeutic Potential, Current Challenges, and Future Therapeutics in Different Types of Cancer;Cells;2023-10-25

5. Antibody-Drug Conjugates for the Treatment of HER2-Positive Breast Cancer;Genes;2022-11-08